Abstract
There are numerous diseases associated with a malfunction of the endothelium, including ischemic injuries that follow thrombotic events, visual loss due to a defective cornea endothelium, and endothelial cell (EC) dysfunction in patients with diabetes. Some of these diseases are susceptible of cell therapies that aim to replace the defective endothelium. Thus, there is a need for a robust, clinically suitable source of autologous ECs. In principle, ECs can be obtained from a variety of autologous tissues, including small diameter veins and the microvasculature of tissues such as skin and adipose. However, the clinical use of mature ECs is limited by site morbidity and low cell proliferation potential. These limitations have motivated the search for other sources of ECs with more proliferative and vasculogenic activities such as those derived from embryonic stem cell (ESCs) and induced pluripotent stem cells (iPSCs). However, ethical considerations along with a poor understanding of the mechanisms controlling the differentiation of embryonic stem cells are hurdles that need to be overcome before these cells can be used in a clinical setting. Alternatively, the existence of postnatal endothelial progenitor cells (EPCs) in circulation represents a promising opportunity to non-invasively obtain large quantities of autologous ECs. However, the process for obtaining EPC-derived ECs has not been straightforward in part due to a lack of consensus regarding EPC definition, origin, and function of these cells. As a result, the term EPCs has been used to define two distinct subpopulations of cells, one with hematopoietic (early EPCs) and the other with endothelial (late EPCs) characteristics. Despite the often-confusing terminology, the functional distinction between these two very different types of EPCs is increasingly better understood. In particular, the ability of late EPCs to generate large amount of endothelial colony-forming cells (ECFCs) is now well recognized. Blood-derived ECFCs represent a robust population of cells with endothelial phenotype and ability to function as bona fide ECs both in vitro and in vivo, and thus, they constitute a promising source of cells for future vascular cell therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G et al (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26(11):1276–1284
Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100(2):158–173
Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321(5889):699–702
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964–967
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85(3):221–228
Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, Jain RK (2008) Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111(3):1302–1305
Bagot CN, Arya R (2008) Virchow and his triad: a question of attribution. Br J Haematol 143(2):180–190
Barrilleaux B, Knoepfler PS (2011) Inducing iPSCs to escape the dish. Cell Stem Cell 9(2):103–111
Bergan JJ, Veith FJ, Bernhard VM, Yao JS, Flinn WR, Gupta SK, Scher LA, Samson RH, Towne JB (1982) Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. Surgery 92(6):921–930
Blancas AA, Shih AJ, Lauer NE, McCloskey KE (2011) Endothelial cells from embryonic stem cells in a chemically defined medium. Stem Cells Dev 20(12):2153–2161
Cao R, Bråkenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9(5):604–613
Carmeliet P (2000) VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 6(10):1102–1103
Chaudhury H, Raborna E, Goldiea LC, Hirschi KK (2012) Stem cell-derived vascular endothelial cells and their potential application in regenerative medicine. Cells Tissues Organs 195:41–47
Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS, Chung HM (2007) Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116(21):2409–2419
Dahl SLM, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT et al (2011) Readily available tissue-engineered vascular grafts. Sci Transl Med 3(68):68ra9
Davison PM, Bensch K, Karasek MA (1980) Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture. J Invest Dermatol 75(4):316–321
De Bie C (2007) Genzyme: 15 years of cell and gene therapy research. Regen Med 2(1):95–97
Descamps B, Emanueli C (2012) Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vascul Pharmacol 56(5–6):267–279
Eberli D, Atala A (2006) Tissue engineering using adult stem cells. Methods Enzymol 420:287–302
Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A (2008) Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 197(2):496–503
Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110(4):624–637
Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med 359(9):938–949
Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N et al (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95(10):3106–3112
Gerecht-Nir S, Ziskind A, Cohen S, Itskovitz-Eldor J (2003) Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest 83:1811–1820
Gimbrone MA, Cotran RS, Folkman J (1974) Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 60(3):673–684
Gonzalez F, Boue S, Izpisua Belmonte JC (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12(4):231–242
Gottlieb D, Kunal T, Emani S, Aikawa E, Brown DW, Powell AJ, Nedder A, Engelmayr GC, Melero-Martin JM, Sacks MS et al (2010) In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg 139(3):723–731
Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, Simari RD (2003) Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93(11):1023–1025
Han Z, Vandevoort CA, Latham KE (2007) Therapeutic cloning: status and prospects. Curr Opin Mol Ther 9(4):392–397
Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R et al (2008) Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133(2):250–264
Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7):593–600
Hirashima M, Kataoka H, Nishikawa S, Matsuyoshi N, Nishikawa S-I (1999) Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 93:1253–1263
Hur J, Yoon C-H, Kim H-S, Choi J-H, Kang H-J, Hwang K-K, Oh B-H, Lee M-M, Park Y-B (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24(2):288–293
Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104(9):2752–2760
Isner JM (2002) Myocardial gene therapy. Nature 415(6868):234–239
Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103(9):1231–1236
Jain RK, Au P, Tam J, Duda DG, Fukumura D (2005) Engineering vascularized tissue. Nat Biotechnol 23(7):821–823
James D, Nam HS, Seandel M, Nolan D, Janovitz T, Tomishima M, Studer L, Lee G, Lyden D, Benezra R et al (2010) Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol 28(2):161–166
Joo HJ, Kim H, Park SW, Cho HJ, Kim HS, Lim DS, Chung HM, Kim I, Han YM, Koh GY (2011) Angiopoietin-1 promotes endothelial differentiation from embryonic stem cells and induced pluripotent stem cells. Blood 118(8):2094–2104
Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97(7):3422–3427
Kane NM, Xiao Q, Baker AH, Luo Z, Xu Q, Emanueli C (2011) Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). Pharmacol Ther 129(1):29–49
Kattman SJ, Huber TL, Keller GM (2006) Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11(5):723–732
Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A et al (2001) Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7(9):1035–1040
Kennedy LJ Jr, Weissman IL (1971) Dual origin of intimal cells in cardiac-allograft arteriosclerosis. N Engl J Med 285(16):884–887
Kern PA, Knedler A, Eckel RH (1983) Isolation and culture of microvascular endothelium from human adipose tissue. J Clin Invest 71(6):1822–1829
Khurana R, Simons M (2003) Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. Trends Cardiovasc Med 13(3):116–122
Langer RS, Vacanti JP (1999) Tissue engineering: the challenges ahead. Sci Am 280(4):86–89
Lee H, Cusick RA, Browne F, Ho Kim T, Ma PX, Utsunomiya H, Langer R, Vacanti JP (2002) Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation 73(10):1589–1593
Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R (2002) Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99(7):4391–4396
Li X, Tjwa M, Moons L, Fons P, Noel A, Ny A, Zhou JM, Lennartsson J, Li H, Luttun A et al (2005) Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J Clin Invest 115(1):118–127
Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105(1):71–77
Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A et al (2009) A chemical platform for improved induction of human iPSCs. Nat Methods 6(11):805–808
Lin R-Z, Dreyzin A, Aamodt K, Dudley AC, Melero-Martin JM (2011) Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant 20:515–522
Lin R-Z, Moreno-Luna R, Zhou B, Pu WT, Melero-Martin JM (2012) Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Angiogenesis 15(3):443–455
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C et al (2010) Executive summary: heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation 121(7):948–954
MacNeil S (2007) Progress and opportunities for tissue-engineered skin. Nature 445(7130):874–880
Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J (2007) In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109(11):4761–4768
Melero-Martin JM, Kang S-Y, Khan ZA, Yuan L, Oettgen P, Bischoff J (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103(2):194–202
Mund JA, Estes ML, Yoder MC, Ingram DA Jr, Case J (2012) Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol 32(4):1045–1053
Murasawa S, Asahara T (2005) Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda) 20:36–42
Nachman RL, Jaffe EA (2004) Endothelial cell culture: beginnings of modern vascular biology. J Clin Invest 114(8):1037–1040
Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R (1999) Functional arteries grown in vitro. Science 284(5413):489–493
Nör JE, Peters MC, Christensen JB, Sutorik MM, Linn S, Khan MK, Addison CL, Mooney DJ, Polverini PJ (2001) Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 81(4):453–463
Park S-W, Koh YJ, Jeon J, Cho Y-H, Jang M-J, Kang Y, Kim M-J, Choi C, Cho YS, Chung H-M et al (2010) Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 116(25):5762–5772
Prater DN, Case J, Ingram DA, Yoder MC (2007) Working hypothesis to redefine endothelial progenitor cells. Leukemia 21(6):1141–1149
Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9(6):702–712
Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107(8):1164–1169
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18(4):399–404
Richardson MR, Yoder MC (2011) Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 50(2):266–272
Rosenzweig A (2003) Endothelial progenitor cells. N Engl J Med 348(7):581–582
Rufaihah AJ, Huang NF, Jame S, Lee JC, Nguyen HN, Byers B, De A, Okogbaa J, Rollins M, Reijo-Pera R et al (2011) Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 31(11):e72–e79
Sacks MS, Schoen FJ, Mayer JE (2009) Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 11:289–313
Schechner JS, Nath AK, Zheng L, Kluger MS, Hughes CC, Sierra-Honigmann MR, Lorber MI, Tellides G, Kashgarian M, Bothwell AL et al (2000) In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A 97(16):9191–9196
Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ (2002) Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 26(4):307–320
Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR et al (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92(2):362–367
Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y et al (2007) Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol 27(10):2127–2134
Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, Mostoslavsky G, Jaenisch R (2010) Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7(1):20–24
Stroncek JD, Grant BS, Brown MA, Povsic TJ, Truskey GA, Reichert WM (2009) Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. Tissue Eng Part A 15(11):3473–3486
Stroncek JD, Ren LC, Klitzman B, Reichert WM (2011) Patient-derived endothelial progenitor cells improve vascular graft patency in a rodent model. Acta Biomater 8(1):201–208
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5(4):434–438
Tatsumi R, Suzuki Y, Sumi T, Sone M, Suemori H, Nakatsuji N (2011) Simple and highly efficient method for production of endothelial cells from human embryonic stem cells. Cell Transplant 20(9):1423–1430
Taura D, Sone M, Homma K, Oyamada N, Takahashi K, Tamura N, Yamanaka S, Nakao K (2009) Induction and isolation of vascular cells from human induced pluripotent stem cells – brief report. Arterioscler Thromb Vasc Biol 29(7):1100–1103
Terry MA (2003) Deep lamellar endothelial keratoplasty (DLEK): pursuing the ideal goals of endothelial replacement. Eye (Lond) 17(8):982–988
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17(R1):R48–R53
Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108(20):2511–2516
Veith FJ, Moss CM, Sprayregen S, Montefusco C (1979) Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity. Surgery 85(3):253–256
Wang R, Clark R, Bautch VL (1992) Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Development 114(2):303–316
Wang ZZ, Au P, Chen T, Shao Y, Daheron LM, Bai H, Arzigian M, Fukumura D, Jain RK, Scadden DT (2007) Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 25(3):317–318
Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A et al (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618–630
Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353(10):999–1007
Wilmut I, Beaujean N, de Sousa PA, Dinnyes A, King TJ, Paterson LA, Wells DN, Young LE (2002) Somatic cell nuclear transfer. Nature 419(6907):583–586
Wu SM, Hochedlinger K (2011) Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 13(5):497–505
Yamahara K, Sone M, Itoh H, Yamashita JK, Yurugi-Kobayashi T, Homma K, Chao TH, Miyashita K, Park K, Oyamada N et al (2008) Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One 3(2):e1666
Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S-I (2000) Flk1-positive cells derived from embryonic stem cells serve as vascular progenitor. Nature 408:92–96
Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, Herron GS (1999) Human endothelial cell life extension by telomerase expression. J Biol Chem 274(37):26141–26148
Yao S, Chen S, Clark J, Hao E, Beattie GM, Hayek A, Ding S (2006) Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci U S A 103(18):6907–6912
Yoder MC (2009) Defining human endothelial progenitor cells. J Thromb Haemost 7(Suppl 1):49–52
Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109(5):1801–1809
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920
Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y et al (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4(5):381–384
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lin, RZ., Moreno-Luna, R., Melero-Martin, J.M. (2014). Vascular Stem Cell Therapy. In: Al-Rubeai, M., Naciri, M. (eds) Stem Cells and Cell Therapy. Cell Engineering, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7196-3_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-7196-3_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7195-6
Online ISBN: 978-94-007-7196-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)